However, despite the plentiful studies examining Ki67 immunohistochemical analysis among multiple cancer types, its adoption into clinical practice has been limited to different regulatory roles, different prognosis values, and varied cutoff values against certain cancer types (28–30). Here, MKI67 is linked to cancer.